Clinical Trial: Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07221578) titled 'Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder' on Oct. 24.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

Study Start Date: Sept. 22

Study Type: INTERVENTIONAL

Condition: Social Anxiety Disorder (SAD)

Intervention: DRUG: VQW-765

oral capsule

DRUG: Placebo

oral capsule

Recruitment Status: RECRUITING

Sponsor: Vanda Pharmaceuticals

Disclaimer: Curated by HT Syndication....